BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1405880)

  • 1. [A pilot study: neuropsychological rehabilitation of patients with solvent-induced toxic encephalopathy].
    Orbaek P; Hagstadius S; Lindgren M; Abjörnsson G
    Lakartidningen; 1992 Sep; 89(36):2845-6, 2851-2. PubMed ID: 1405880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Encephalopathy and polyneuropathy induced by organic solvents.
    Berstad J; Flekkøy K; Pedersen ON
    J Oslo City Hosp; 1989; 39(6-7):81-6. PubMed ID: 2778557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neuropsychology in occupational rehabilitation: a new field of intervention?].
    Müller SV; Klaue U; Specht A; Schulz P
    Rehabilitation (Stuttg); 2007 Apr; 46(2):93-101. PubMed ID: 17464904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychosocial and cognitive rehabilitation of patients with solvent-induced chronic toxic encephalopathy: a randomised controlled study.
    van Hout MS; Wekking EM; Berg IJ; Deelman BG
    Psychother Psychosom; 2008; 77(5):289-97. PubMed ID: 18560254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic solvent-induced encephalopathy: European consensus of neuropsychological characteristics, assessment, and guidelines for diagnostics.
    van Valen E; van Thriel C; Akila R; Nilson LN; Bast-Pettersen R; Sainio M; van Dijk F; van der Laan G; Verberk M; Wekking E
    Neurotoxicology; 2012 Aug; 33(4):710-26. PubMed ID: 22498091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decision rules for assessment of chronic solvent-induced encephalopathy: Results in 2370 patients.
    Verberk MM; van der Hoek JA; van Valen E; Wekking EM; van Hout MS; Hageman G; van der Laan G; van Dijk FJ
    Neurotoxicology; 2012 Aug; 33(4):742-52. PubMed ID: 22722000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychological assessment of toxic encephalopathy.
    White RF; Feldman RG
    Am J Ind Med; 1987; 11(4):395-8. PubMed ID: 3578292
    [No Abstract]   [Full Text] [Related]  

  • 8. Magnetic resonance imaging (MRI), neurobehavioral testing, and toxic encephalopathy: two cases.
    White RF; Feldman RG; Moss MB; Proctor SP
    Environ Res; 1993 Apr; 61(1):117-23. PubMed ID: 8472665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis in chronic toxic encephalopathy. A two-year follow-up study in 26 house painters with occupational encephalopathy.
    Bruhn P; Arlien-Søborg P; Gyldensted C; Christensen EL
    Acta Neurol Scand; 1981 Oct; 64(4):259-72. PubMed ID: 7315195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic toxic encephalopathy among house painters with disability pension.
    Tvedt B; Skyberg K; Berstad J
    J Oslo City Hosp; 1989; 39(6-7):74-80. PubMed ID: 2528611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solvent-induced toxic encephalopathy: electrophysiological data in relation to neuropsychological findings.
    Lindgren M; Osterberg K; Orbaek P; Rosén I
    J Clin Exp Neuropsychol; 1997 Oct; 19(5):772-83. PubMed ID: 9408804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P300 of auditory event related potentials in occupational chronic solvent encephalopathy.
    Keski-Säntti P; Holm A; Akila R; Tuisku K; Kovala T; Sainio M
    Neurotoxicology; 2007 Nov; 28(6):1230-6. PubMed ID: 17869344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Social and psychological rehabilitation of patients with chronic brain lesions caused by organic solvents: a Danish experience].
    Rasmussen KS; Christensen EA
    Cah Sociol Demogr Med; 1991; 31(1):57-66. PubMed ID: 2070269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Solvent-induced lesions in Tröndelag. How were they treated?].
    Leira HL; Bratt U; Gustafsson O; Saksvik PO
    Tidsskr Nor Laegeforen; 1990 Nov; 110(28):3623-6. PubMed ID: 2260062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective clinical and psychometric investigation of patients with chronic toxic encephalopathy induced by solvents.
    Orbaek P; Lindgren M
    Scand J Work Environ Health; 1988 Feb; 14(1):37-44. PubMed ID: 3353695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of age, neuropsychological impairment, and medication on regional cerebral blood flow in schizophrenia and major affective disorder.
    Goldstein PC; Brown GG; Marcus A; Ewing JR
    Henry Ford Hosp Med J; 1990; 38(4):202-6. PubMed ID: 1982284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colour vision defects in occupational chronic solvent encephalopathy.
    Päällysaho J; Näsänen R; Mäntyjärvi M; Kaukiainen A; Sainio M
    Hum Exp Toxicol; 2007 Apr; 26(4):375-83. PubMed ID: 17615120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropsychological performance of journeymen painters under acute solvent exposure and exposure-free conditions.
    Morrow LA; Steinhauer SR; Condray R; Hodgson M
    J Int Neuropsychol Soc; 1997 May; 3(3):269-75. PubMed ID: 9161106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organic solvent-induced encephalopathy in industrial painters.
    Linz DH; de Garmo PL; Morton WE; Wiens AN; Coull BM; Maricle RA
    J Occup Med; 1986 Feb; 28(2):119-25. PubMed ID: 3950785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.